Quantcast
Home > Quotes > LMAT
LMAT

LeMaitre Vascular, Inc. Common Stock (LMAT) Quote & Summary Data

$26.24
*  
0.36
1.35%
Get LMAT Alerts
*Delayed - data as of May 23, 2019  -  Find a broker to begin trading LMAT now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 26.65 / $ 25.94
Share Volume
86,499
50 Day Avg. Daily Volume
142,365
Previous Close
$ 26.60
52 Week High / Low
$ 38.995 / $ 21.79
Market Cap
516,173,128
Annualized Dividend
$ .34
Ex Dividend Date
5/21/2019
Dividend Payment Date
6/6/2019
Current Yield
1.28 %

Intraday Chart

Shares Traded

Share Volume:
86,499
50 Day Avg. Daily Volume:
142,365

P/E Ratio

P/E Ratio:
23.64
Forward P/E (1y):
32.05
Earnings Per Share (EPS):
$ 1.11

Trading Range

The current last sale of $26.24 is 20.42% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 26.65 $ 38.995
 Low: $ 25.94 $ 21.79

Company Description (as filed with the SEC)

LeMaitre Vascular is a global provider of medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. We develop, manufacture, and market vascular devices to address the needs of vascular surgeons. Our diversified portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart and are well known to vascular surgeons, and includes the LeMaitre valvulotome, the XenoSure biologic patch, the Pruitt F3 carotid shunt, VascuTape radiopaque tape, and Syntel, Python and Latis embolectomy catheters. Our principal product offerings are sold throughout the world, primarily in the United States, Europe and, to a lesser extent, Asia and the Pacific Rim. We estimate that the annual worldwide market that our core product lines address is approximately $900 million. We sell our products and services primarily through a direct sales force.  ... More ...  



Risk Grade

Where does LMAT fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 26.38
Open Date:
May 23, 2019
Close Price:
$ 26.24
Close Date:
May 23, 2019


Consensus Recommendation

Analyst Info